Insights

Innovative Platform Acrivon Therapeutics leverages a proprietary Generative Phosphoproteomics AP3 platform that enhances precision oncology drug development, presenting opportunities to collaborate on advanced biomarker discovery and targeted therapies.

Recent Funding Success The company secured $130 million in recent financing, indicating strong investor confidence and potential for expanded R&D collaborations and strategic partnerships.

Regulatory Recognition With its ACR-368 OncoSignature assay receiving FDA Breakthrough Device designation, Acrivon is positioned to fast-track clinical development, offering opportunities to engage in companion diagnostics and personalized treatment solutions.

Scientific Leadership Acrivon's active presence at major cancer research conferences and its focus on preclinical data showcase a commitment to innovation, which can attract partnerships for joint research or clinical trial support.

Market Position Operating in the precision oncology space with a specialized platform and clinical-stage assets, Acrivon offers potential sales opportunities in advanced therapeutics, biomarker assays, and precision medicine collaborations with biotech and pharma companies.

Acrivon Therapeutics, Inc. Tech Stack

Acrivon Therapeutics, Inc. uses 8 technology products and services including Cloudflare, CookieYes, Shopify, and more. Explore Acrivon Therapeutics, Inc.'s tech stack below.

Cloudflare

Content Management System

CookieYes

Cookie Compliance

Shopify

E-commerce

Vue.js

Javascript Frameworks

JSON-LD

Javascript Frameworks

Python

Programming Languages

reCAPTCHA

Security

X-Content-Type-Options

Web & Portal Technology

Acrivon Therapeutics, Inc. Email Formats	Example	Percentage
FLast@acrivon.com	JDoe@acrivon.com	94%
FMiddleLast@acrivon.com	JMichaelDoe@acrivon.com	4%
First@acrivon.com	John@acrivon.com	1%
FL@acrivon.com	JD@acrivon.com	1%

Acrivon Therapeutics, Inc. Email Formats

Example

Percentage

FLast@acrivon.com

JDoe@acrivon.com

94%

FMiddleLast@acrivon.com

JMichaelDoe@acrivon.com

First@acrivon.com

John@acrivon.com

FL@acrivon.com

JD@acrivon.com

Frequently Asked Questions

Where is Acrivon Therapeutics, Inc.'s headquarters located?

Acrivon Therapeutics, Inc.'s main headquarters is located at 700 North Main Street Cambridge, Massachusetts 02139 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Acrivon Therapeutics, Inc.'s stock symbol?

Acrivon Therapeutics, Inc. is a publicly traded company; the company's stock symbol is ACRV.

What is Acrivon Therapeutics, Inc.'s official website and social media links?

Acrivon Therapeutics, Inc.'s official website is acrivon.com and has social profiles on LinkedIn Crunchbase.

What is Acrivon Therapeutics, Inc.'s SIC code NAICS code?

Acrivon Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Acrivon Therapeutics, Inc. have currently?

As of May 2026, Acrivon Therapeutics, Inc. has approximately 83 employees across 2 continents, including North AmericaEurope. Key team members include Chief Legal Officer: M. M.Chief Operating Officer: E. D.Chief Financial Officer: A. L.. Explore Acrivon Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Acrivon Therapeutics, Inc. belong to?

Acrivon Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Acrivon Therapeutics, Inc. use?

Acrivon Therapeutics, Inc.'s tech stack includes CloudflareCookieYesShopifyVue.jsJSON-LDPythonreCAPTCHAX-Content-Type-Options.

What is Acrivon Therapeutics, Inc.'s email format?

Acrivon Therapeutics, Inc.'s email format typically follows the pattern of FLast@acrivon.com. Find more Acrivon Therapeutics, Inc. email formats with LeadIQ.

When was Acrivon Therapeutics, Inc. founded?

Acrivon Therapeutics, Inc. was founded in 2018.

Acrivon Therapeutics, Inc.

Q: How many employees does Acrivon Therapeutics, Inc. have currently?

Acrivon Therapeutics, Inc. has approximately 83 employees.

Q: What technology does Acrivon Therapeutics, Inc. use?

Acrivon Therapeutics, Inc.'s tech stack includes Microsoft Word, oEmbed, Cloudflare Bot Management, Shopify, Onsen UI.

Q: What is Acrivon Therapeutics, Inc.'s NAICS code?

Acrivon Therapeutics, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchMassachusetts, United States51-200 Employees

Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Our method is widely applicable across drug classes and modalities. We specifically apply our approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single gene driver mutations or synthetic lethal contexts. Leveraging our unique patient selection platform, Acrivon Therapeutics aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials. Acrivon Therapeutics and its clinical biomarker development group is headquartered in the greater Boston area, with biomarker discovery efforts concentrated in our wholly-owned subsidiary in Lund, Sweden.

Insights

Similar companies to Acrivon Therapeutics, Inc.

Arvinas

Atara Biotherapeutics

Kiniksa Pharmaceuticals

Alkermes

Modulus Therapeutics

Dova Pharmaceuticals

Alnylam Pharmaceuticals

Sage Therapeutics

Akebia Therapeutics

Ascendis Pharma

Ovid Therapeutics